Evaluation of good review practices in member authorities of the East African Medicines Regulatory Harmonisation initiative: strategies for alignment with African medicines agency

被引:1
|
作者
Ngum, Nancy [1 ,2 ]
Ndomondo-Sigonda, Margareth [2 ]
Habonimana, Remy [3 ]
Siyoi, Fred [4 ]
Irasabwa, Clarisse [5 ]
Ojukwu, Julia [6 ]
Apolinary, Felchism [7 ]
Okello, Andrew [8 ]
Ahmada, Sabrina [9 ]
Walker, Stuart [1 ,10 ]
Salek, Sam [1 ,11 ]
机构
[1] Univ Hertfordshire, Sch Life & Med Sci, Dept Clin & Pharmaceut Sci, Hatfield, England
[2] African Union Dev Agcy New Partnership Afr Dev AUD, Johannesburg, South Africa
[3] Burundi Food & Med Regulatory Author ABREMA, Bujumbura, Burundi
[4] Pharmacy & Poisons Board PPB, Nairobi, Kenya
[5] Rwanda Food & Drugs Author, Kigali, Rwanda
[6] Drug & Food Control Author DFCA, Juba, South Sudan
[7] Tanzania Med & Med Devices Author TMDA, Dodoma, Tanzania
[8] Natl Drug Author, Kampala, Uganda
[9] Zanzibar Food & Drugs Author ZFDA, Dodoma, Tanzania
[10] Ctr Innovat Regulatory Sci, London, England
[11] Inst Med Dev, London, England
关键词
East African Medicines Regulatory Harmonisation (EAC-MRH); good assessment procedure; good review practices; regulatory reliance; African Medicines Agency (AMA);
D O I
10.3389/fmed.2024.1437970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The East African Community Medicines Regulatory Harmonisation (EAC-MRH) programme was established to address challenges faced by national regulatory authorities (NRAs) of the region. Work sharing through joint assessments and inspections was adopted to manage limited resources and capacity; however, NRA good review practices (GrevP) are also a key determinant to success. This study evaluated GReVP among the EAC-MRH NRAs and mapped required strategies for countries to align themselves with the African Medicines Agency (AMA).Methods A validated questionnaire (Optimising Efficiency in Regulatory Agency-OpERA) that standardises and captures review processes was completed by the head of the medicines registration division in each NRA. A country report based on the completed questionnaire was developed for each NRA and validated by the heads of the respective authorities.Results The population and size of the NRAs vary and four of the countries have semi-autonomous authorities and three NRAs are autonomous. The Burundi and South Sudan authorities were fully government funded, Kenya and Uganda entirely from fees, while Rwanda, Tanzania and Zanzibar were partially funded from different sources. All authorities except South Sudan, which does not receive or review applications had backlogs. Authority fees varied based on the different application categories. Key milestones for standardised regulatory processes are implemented in all authorities. Queue times range from a few weeks to about one year. Three NRAs use internal technical agency staff for scientific assessments and three use both internal and external experts. Clock stop time varies and target timelines for review committee range from one day to three months. All the NRAs implement some best practices on quality measures, transparency and communication. Some have activities for transparency improvement but with minimal attention to training and education. Most employ some quality decision-making practices.Discussion GrevP in EAC-MRH NRAs still needs to be improved and it is imperative that these authorities streamline and harmonise their practices. Increasing human resources and an investment in training and education of staff will enable the implementation of all measures for GRevP. This is vital, as the effectiveness and efficiency of the AMA will depend on the strength of these NRAs.
引用
收藏
页数:10
相关论文
共 29 条
  • [1] Evaluation of the review models and approval timelines of authorities participating in the East African Medicine Regulatory Harmonisation initiative: alignment and strategies for moving forward
    Ngum, Nancy
    Ndomondo-Sigonda, Margareth
    Habonimana, Remy
    Siyoi, Fred
    Irasabwa, Clarisse
    Ojukwu, Julia
    Apolinary, Felchism
    Okello, Andrew
    Ahmada, Sabrina
    Walker, Stuart
    Salek, Sam
    FRONTIERS IN MEDICINE, 2024, 11
  • [2] National medicines regulatory authorities financial sustainability in the East African Community
    Ndomondo-Sigonda, Margareth
    Miot, Jacqueline
    Naidoo, Shan
    Ng'andu, Brian
    Ngum, Nancy
    Masota, Nelson E.
    Kaale, Eliangiringa
    PLOS ONE, 2020, 15 (07):
  • [3] Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African Medicines Agency
    Ngum, Nancy
    Ndomondo-Sigonda, Margareth
    Walker, Stuart
    Salek, Sam
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2023, 145
  • [4] Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency
    Ncube, Bakani Mark
    Dube, Admire
    Ward, Kim
    PHARMACEUTICAL MEDICINE, 2022, 36 (02) : 83 - 97
  • [5] Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency
    Bakani Mark Ncube
    Admire Dube
    Kim Ward
    Pharmaceutical Medicine, 2022, 36 : 83 - 97
  • [6] Medicines regulatory science expertise in Africa: Workforce capacity development and harmonisation activities towards the establishment of the African Medicines Agency
    Ncube, Bakani Mark
    Dube, Admire
    Ward, Kim
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 660 - 660
  • [7] Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiative
    Giaquinto, Alexander R.
    Grignolo, Alberto
    Liberti, Lawrence
    Lim, John C. W.
    Salmonson, Tomas
    Sauer, Fernand
    Ukwu, Henrietta
    PLOS MEDICINE, 2020, 17 (08)
  • [8] Comparison of good review practices of seven countries participating in the ECOWAS medicines regulatory harmonisation initiative: identifying opportunities for improvement
    Owusu-Asante, Mercy
    Darko, Delese Mimi
    Seaneke, Seth
    Nacoulma, Aminata
    Traore, Oula Ibrahim Olivier
    Adeyeye, Christianah Mojisola
    Akinyemi, Abayomi
    Assane, Coulibaly
    Clamoungou, Clarisse epse Kaul Meledje
    Ndao, Oumy Kalsoum
    Kande, Rokhaya Ndiaye
    Komeh, James
    Mansaray, Sheku
    Lamboni, Dalkoi
    Agba, Maheza
    Walker, Stuart
    Salek, Sam
    FRONTIERS IN MEDICINE, 2025, 11
  • [9] Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiative
    Sillo, Hiiti
    Ambali, Aggrey
    Azatyan, Samvel
    Chamdimba, Chimwemwe
    Kaale, Eliangiringa
    Kabatende, Joseph
    Lumpkin, Murray
    Mashingia, Jane H.
    Mukanga, David
    Nyabenda, Bonaventure
    Sematiko, Gordon
    Sigonda, Margareth
    Simai, Burhani
    Siyoi, Fred
    Sonoiya, Stanley
    Ward, Mike
    Ahonkhai, Vincent
    PLOS MEDICINE, 2020, 17 (08)
  • [10] The African Medicines Regulatory Harmonization Initiative: Rationale and Benefits
    Ndomondo-Sigonda, M.
    Ambali, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (02) : 176 - 178